Cargando…

Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy

Background: Pertussis occurs in older children, adolescents and adults due to waning immunity after primary vaccination. Booster vaccination for pre-school children has been recommended in Italy since 1999. In this study (NCT00871000), the immunogenicity, safety and reactogenicity of a booster dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrera, Giuseppe, Cuccia, Mario, Mereu, Gabriele, Icardi, Giancarlo, Bona, Gianni, Esposito, Susanna, Marchetti, Federico, Messier, Marc, Kuriyakose, Sherine, Hardt, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426082/
https://www.ncbi.nlm.nih.gov/pubmed/22327497
http://dx.doi.org/10.4161/hv.18650
_version_ 1782241464356438016
author Ferrera, Giuseppe
Cuccia, Mario
Mereu, Gabriele
Icardi, Giancarlo
Bona, Gianni
Esposito, Susanna
Marchetti, Federico
Messier, Marc
Kuriyakose, Sherine
Hardt, Karin
author_facet Ferrera, Giuseppe
Cuccia, Mario
Mereu, Gabriele
Icardi, Giancarlo
Bona, Gianni
Esposito, Susanna
Marchetti, Federico
Messier, Marc
Kuriyakose, Sherine
Hardt, Karin
author_sort Ferrera, Giuseppe
collection PubMed
description Background: Pertussis occurs in older children, adolescents and adults due to waning immunity after primary vaccination. Booster vaccination for pre-school children has been recommended in Italy since 1999. In this study (NCT00871000), the immunogenicity, safety and reactogenicity of a booster dose of reduced-antigen content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine (dTpa-IPV; GSK Biologicals Boostrix™-Polio; 3-component pertussis) vs. full-strength DTPa-IPV vaccine (sanofi-pasteur—MSD Tetravac™; 2-component pertussis) was evaluated in pre-school Italian children.   Methods: Healthy children aged 5–6 y primed in a routine vaccination setting with three doses of DTPa-based vaccines were enrolled and randomized (1:1) in this phase IIIb, booster study to receive a single dose of dTpa-IPV or DTPa-IPV; the MMRV vaccine was co-administered. Antibody concentrations/titers against diphtheria, tetanus, pertussis and poliovirus 1–3 were measured before and one month post-booster. Reactogenicity and safety was assessed. Results: 305 subjects were enrolled of whom 303 (dTpa-IPV = 151; DTPa-IPV = 152) received booster vaccination. One month post-booster, all subjects were seroprotected/seropositive for anti-diphtheria, anti-tetanus, anti-PT, anti-FHA and anti-poliovirus 1–3; 99.3% of dTpa-IPV and 60.4% of DTPa-IPV subjects were seropositive for anti-PRN; 98–100% of subjects were seropositive against MMRV antigens post-booster. Pain at the injection site (dTpa-IPV: 63.6%; DTPa-IPV: 63.2%) and fatigue (dTpa-IPV: 26.5%; DTPa-IPV: 23.7%) were the most commonly reported solicited local and general symptoms, during the 4-d follow-up period. No SAEs or fatalities were reported. Conclusions: The reduced-antigen-content dTpa-IPV vaccine was non-inferior to full-strength DTPa-IPV vaccine with respect to immunogenicity. The vaccine was well-tolerated and can be confidently used as a booster dose in pre-school children.
format Online
Article
Text
id pubmed-3426082
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-34260822012-08-24 Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy Ferrera, Giuseppe Cuccia, Mario Mereu, Gabriele Icardi, Giancarlo Bona, Gianni Esposito, Susanna Marchetti, Federico Messier, Marc Kuriyakose, Sherine Hardt, Karin Hum Vaccin Immunother Research Paper Background: Pertussis occurs in older children, adolescents and adults due to waning immunity after primary vaccination. Booster vaccination for pre-school children has been recommended in Italy since 1999. In this study (NCT00871000), the immunogenicity, safety and reactogenicity of a booster dose of reduced-antigen content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine (dTpa-IPV; GSK Biologicals Boostrix™-Polio; 3-component pertussis) vs. full-strength DTPa-IPV vaccine (sanofi-pasteur—MSD Tetravac™; 2-component pertussis) was evaluated in pre-school Italian children.   Methods: Healthy children aged 5–6 y primed in a routine vaccination setting with three doses of DTPa-based vaccines were enrolled and randomized (1:1) in this phase IIIb, booster study to receive a single dose of dTpa-IPV or DTPa-IPV; the MMRV vaccine was co-administered. Antibody concentrations/titers against diphtheria, tetanus, pertussis and poliovirus 1–3 were measured before and one month post-booster. Reactogenicity and safety was assessed. Results: 305 subjects were enrolled of whom 303 (dTpa-IPV = 151; DTPa-IPV = 152) received booster vaccination. One month post-booster, all subjects were seroprotected/seropositive for anti-diphtheria, anti-tetanus, anti-PT, anti-FHA and anti-poliovirus 1–3; 99.3% of dTpa-IPV and 60.4% of DTPa-IPV subjects were seropositive for anti-PRN; 98–100% of subjects were seropositive against MMRV antigens post-booster. Pain at the injection site (dTpa-IPV: 63.6%; DTPa-IPV: 63.2%) and fatigue (dTpa-IPV: 26.5%; DTPa-IPV: 23.7%) were the most commonly reported solicited local and general symptoms, during the 4-d follow-up period. No SAEs or fatalities were reported. Conclusions: The reduced-antigen-content dTpa-IPV vaccine was non-inferior to full-strength DTPa-IPV vaccine with respect to immunogenicity. The vaccine was well-tolerated and can be confidently used as a booster dose in pre-school children. Landes Bioscience 2012-03-01 /pmc/articles/PMC3426082/ /pubmed/22327497 http://dx.doi.org/10.4161/hv.18650 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Research Paper
Ferrera, Giuseppe
Cuccia, Mario
Mereu, Gabriele
Icardi, Giancarlo
Bona, Gianni
Esposito, Susanna
Marchetti, Federico
Messier, Marc
Kuriyakose, Sherine
Hardt, Karin
Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
title Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
title_full Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
title_fullStr Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
title_full_unstemmed Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
title_short Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
title_sort booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: a randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426082/
https://www.ncbi.nlm.nih.gov/pubmed/22327497
http://dx.doi.org/10.4161/hv.18650
work_keys_str_mv AT ferreragiuseppe boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT cucciamario boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT mereugabriele boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT icardigiancarlo boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT bonagianni boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT espositosusanna boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT marchettifederico boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT messiermarc boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT kuriyakosesherine boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy
AT hardtkarin boostervaccinationofpreschoolchildrenwithreducedantigencontentdiphtheriatetanusacellularpertussisinactivatedpoliovirusvaccinecoadministeredwithmeaslesmumpsrubellavaricellavaccinearandomizedcontrolledtrialinchildrenprimedaccordingtoa21scheduleininfancy